Hypertrophic Cardiomyopathy Pilot Study



Status:Active, not recruiting
Conditions:High Cholesterol, Peripheral Vascular Disease, Cardiology, Cardiology, Orthopedic
Therapuetic Areas:Cardiology / Vascular Diseases, Orthopedics / Podiatry
Healthy:No
Age Range:18 - 99
Updated:8/23/2018
Start Date:September 2016
End Date:June 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Pilot Observational Case-control Study of the Electrical Heterogeneity in Patients With Hypertrophic Cardiomyopathy and High Arrhythmic Risk

This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in
comparison to patients with well-understood arrhythmogenic substrate (ischemic
cardiomyopathy), as well as to individuals free from arrhythmogenic substrate


Inclusion Criteria:

- Diagnosed HCM

- Documented history of sustained ventricular tachyarrhythmia or resuscitated sudden
cardiac arrest

- Maximal left ventricular wall thickness of > 30mm

- Extensive fibrosis on cardiac MRI (>15% of total myocardial volume)

- >7.5%/5-year risk of sudden cardiac death as determined by HCM risk-SCD

Exclusion Criteria:

- age < 18 years

- Pregnancy

- Atrial Fibrillation
We found this trial at
1
site
Oregon Health and Science University
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials